|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||
| Current assets: | ||||||||||||||
| Cash and cash equivalents | ||||||||||||||
| Restricted cash | ||||||||||||||
| Accounts receivable, net | ||||||||||||||
| Derivatives | ||||||||||||||
| Inventories, net | ||||||||||||||
| Vendor deposits | ||||||||||||||
| Loan receivable | ||||||||||||||
| Prepaid expenses and other current assets | ||||||||||||||
| Total current assets | ||||||||||||||
| Property and equipment, net | ||||||||||||||
| Right-of-use-assets | ||||||||||||||
| Intangible assets, net | ||||||||||||||
| Long-term inventories, net | ||||||||||||||
| Vendor deposits long term | ||||||||||||||
| Deferred offering costs | ||||||||||||||
| Digital assets | ||||||||||||||
| Goodwill | ||||||||||||||
| Other assets | ||||||||||||||
| Total Assets | ||||||||||||||
| Liabilities and stockholders' equity | ||||||||||||||
| Current liabilities: | ||||||||||||||
| Accounts payable | ||||||||||||||
| Accrued expenses and other current liabilities | ||||||||||||||
| Operating lease liability, current portion | ||||||||||||||
| Deferred revenue | ||||||||||||||
| Loans payable | ||||||||||||||
| Senior secured notes | ||||||||||||||
| Income tax payable | ||||||||||||||
| Derivatives | ||||||||||||||
| Mandatorily redeemable Series D convertible preferred stock | ||||||||||||||
| Convertible notes payable, net | ||||||||||||||
| Total current liabilities | ||||||||||||||
| Operating lease liability, net of current portion | ||||||||||||||
| Mandatorily redeemable Series D convertible preferred stock | ||||||||||||||
| Other long term liabilities | ||||||||||||||
| Warrant liabilities | ||||||||||||||
| Loans payable - long-term | ||||||||||||||
| Convertible notes payable non current, net | ||||||||||||||
| Total liabilities | ||||||||||||||
| Series E convertible preferred stock, par value $0.0001; 1,300,000 shares authorized, issued and outstanding as of June 30, 2026 and December 31, 2025. | ||||||||||||||
| Stockholders' equity | ||||||||||||||
| Preferred stock value | ||||||||||||||
| Series A Preferred Stock | ||||||||||||||
| Series B Preferred Stock | ||||||||||||||
| Series C Preferred Stock | ||||||||||||||
| Series A Convertible Preferred Stock | ||||||||||||||
| Series B Convertible Preferred Stock | ||||||||||||||
| Series C Convertible Preferred Stock | ||||||||||||||
| Series E Convertible Preferred Stock | ||||||||||||||
| Series A Preferred Stock subscription receivable, 1,500,000 shares | ||||||||||||||
| Common stock, par value $0.0001; 900,000,000 shares authorized; 514,467 and 43,930 shares issued and outstanding as of June 30, 2026 and December 31, 2025. | ||||||||||||||
| Additional paid-in capital | ||||||||||||||
| Treasury stock, at cost | ||||||||||||||
| Accumulated other comprehensive income | ||||||||||||||
| Accumulated deficit | ||||||||||||||
| Total stockholders' equity | ||||||||||||||
| Total liabilities, preferred stock and stockholders' equity |
Loading...